Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Hsp90 is a molecular chaperone for many signal transducers and may influence evolution by releasing previously silent genetic variation in response to environmental change. In fungi separated by ∼800 million years of evolution, Hsp90 potentiated the evolution of drug resistance in a different way, by enabling new mutations to have immediate phenotypic consequences. Resistance was abrogated by Hsp90 inhibitors and by febrile temperatures, suggesting new therapeutic strategies and a clinical benefit of fever. During selection in a human host, drug resistance that was initially Hsp90-dependent evolved toward independence. Thus, Hsp90 can act in diverse ways to couple environmental contingency to the emergence and fixation of new traits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibitors of heat shock protein 90 (Hsp90)82, calcineurin21,25,26, target of rapamycin (TOR)83 and mutants that affect Rim10184 (a transcription factor involved in the pH response pathway) effectively eliminate tolerance and greatly increase the fungicidal activity [G] of fluconazole across a diverse set of isolates with different tolerance levels (Fig. 1E; Box 5).”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [82]
In the citing paper
“The importance of rendering FLC fungicidal in treating IFIs arises from the increasing prevalence of acquired FLC resistance and the persistent nature of fungal infections attributed to the fungistatic properties of FLC [10,11,12].”
From Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species (2024) · cites this paper as [10]
In the citing paper
“When large numbers of cells are plated on a high concentration of fluconazole, a rapid adaptation to decreased susceptibility has been observed in wild-type cells (25).”
From Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants (2013) · cites this paper as [25]
In the citing paper
“A strain with genetically reduced Hsp90 levels (Lo90 [21]) had a modest reduction in tolerance, however, a concentration the Hsp90 inhibitor GdA that abrogates azole resistance had no effect on MF tolerance (Figure 9D).”
From Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin (2009) · cites this paper as [21]
In the citing paper
“A strain with genetically reduced Hsp90 levels (Lo90 [21]) had a modest reduction in tolerance, however, a concentration the Hsp90 inhibitor GdA that abrogates azole resistance had no effect on MF tolerance (Figure 9D).”
From Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin (2009) · cites this paper as [21]
42 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hsp90 as a capacitor for morphological evolution
Rutherford, S. L., & Lindquist, S. (1998) · Nature · doi:10.1038/24550 · Cited by 2,270
Self-citationPratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Hsp90 as a capacitor of phenotypic variation
Queitsch, C., Sangster, T. A., & Lindquist, S. (2002) · Nature · doi:10.1038/nature749 · Cited by 1,372
Self-citationClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202
Kirschner, M., & Gerhart, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8420 · Cited by 1,129
Molecular Evidence for the Early Colonization of Land by Fungi and Plants
Heckman, D. S., Geiser, D. M., Eidell, B. R., Stauffer, R. L., Kardos, N. L., & Hedges, S. B. (2001) · Science · doi:10.1126/science.1061457 · Cited by 1,020
Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004
Young, J. C., Moarefi, I., & Hartl, F. U. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104079 · Cited by 822
Research works printed but not linked: 1
- J. R. Blankenship, W. J. Steinbach, J. R. Perfect, J. Heitman, Curr. Opin. Investig. Drugs4, 192 (2003).
Cited by
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Self-citationWorldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555
Biological and Chemical Approaches to Diseases of Proteostasis Deficiency
Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W., & Balch, W. E. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.114844 · Cited by 1,149
Shen, D.-W., Pouliot, L. M., Hall, M. D., & Gottesman, M. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005637 · Cited by 955
“Cowen and colleagues (Cowen and Lindquist, 2005; Cowen et al., 2009) also demonstrated that HSP90 plays an important role in the drug resistance of yeast and fungus and could be a target for clinical therapy of yeast- and fungus-induced diseases.”
BackgroundCellProfiler™: Free, Versatile Software for Automated Biological Image Analysis
Lamprecht, M. R., Sabatini, D. M., & Carpenter, A. E. (2007) · BioTechniques · doi:10.2144/000112257 · Cited by 895
Adaptive laboratory evolution—Principles and applications for biotechnology
Dragosits, M., & Mattanovich, D. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-64 · Cited by 827
“Moreover, there is evidence that the interplay of protein mutational robustness, protein folding and environmental stress is an additional key factor that determines the evolution of new traits [145,146].”
BackgroundAntifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Self-citationAneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
Segal, B. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0808853 · Cited by 661
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Arbuscular mycorrhiza and heavy metal tolerance
Hildebrandt, U., Regvar, M., & Bothe, H. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2006.09.023 · Cited by 650
“HSP90, an abundant, evolutionarily conserved and highly stress-inducible molecular chaperone, regulates folding, transport, maturation and degradation of a variety of proteins (Cowen and Lindquist, 2005; Sangster and Queitsch, 2005).”
BackgroundMechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
“Inhibition of Hsp90 can also block the evolution of azole resistance, and abrogate resistance caused by the loss of function of Erg3 or resistance that evolved in a human host by multiple mechanisms (Cowen and Lindquist 2005; Cowen et al. 2006).”
BackgroundSelf-citationVerghese, J., Abrams, J., Wang, Y., & Morano, K. A. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05018-11 · Cited by 575
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
The role of developmental plasticity in evolutionary innovation
Moczek, A. P., Sultan, S., Foster, S., Ledón-Rettig, C., Dworkin, I., Nijhout, H. F., Abouheif, E., & Pfennig, D. W. (2011) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2011.0971 · Cited by 594
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
“albicans, at least in part via calcineurin [179].”
BackgroundRegulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
“This dependence gradually evolved toward Hsp90 and calcineurin independence, corresponding with an upregulation of multidrug transporters (115).”
BackgroundInfluentialSelf-citationWandinger, S. K., Richter, K., & Buchner, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800007200 · Cited by 546
Combination antifungal therapy
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., & Rex, J. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.693-715.2004 · Cited by 541
Microbial Cell Individuality and the Underlying Sources of Heterogeneity
Avery, S. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1460 · Cited by 521
“albicans that is sensitive to the function of the molecular chaperone Hsp90 ; in this case, however, the variability is apparently of genotypic origi”
BackgroundAntifungal drug resistance: evolution, mechanisms and impact
Revie, N. M., Iyer, K. R., Robbins, N., & Cowen, L. E. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.02.005 · Cited by 516
Self-citationSionov, E., Lee, H., Chang, Y. C., & Kwon-Chung, K. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000848 · Cited by 479
“Hsp90 that may facilitate the cells to respond to drug stress [21,22].”
BackgroundCan we rationally design promiscuous drugs?
HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469
Molecular Evolution of Antifungal Drug Resistance
Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441
Self-citationMutational effects and the evolution of new protein functions
Soskine, M., & Tawfik, D. S. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2808 · Cited by 454
Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network
Kang, B. H., Plescia, J., Dohi, T., Rosa, J., Doxsey, S. J., & Altieri, D. C. (2007) · Cell · doi:10.1016/j.cell.2007.08.028 · Cited by 443
“This selectivity emphasizes how broadly Hsp90-directed protein folding is exploited during oncogenic transformation and is ideally suited to preserve steady-state mitochondrial integrity, elevate the organelle threshold for initiation of cell death (Green and Kroemer, 2004) during cellular or environmental stress (Bee…”
BackgroundProtein Folding in the Cytoplasm and the Heat Shock Response
Vabulas, R. M., Raychaudhuri, S., Hayer-Hartl, M., & Hartl, F. U. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004390 · Cited by 428
“This observation is in line with the proposed role of Hsp90 as an evolutionarycapacitor in protecting mutated and thus destabilized forms of proteins from degradation (Rutherford and Lindquist 1998; Queitsch et al. 2002; Cowen and Lindquist 2005).”
BackgroundCowen, L. E., Singh, S. D., Köhler, J. R., Collins, C., Zaas, A. K., Schell, W. A., Aziz, H., Mylonakis, E., Perfect, J. R., Whitesell, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813394106 · Cited by 413
“terreus (15), we postulated that Hsp90 inhibitors would have synergistic effects with echinocandins.”
BackgroundMethodInfluentialSelf-citationThe EGF receptor family: spearheading a merger of signaling and therapeutics
Bublil, E. M., & Yarden, Y. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.008 · Cited by 397
Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000532 · Cited by 362
“The key mediator of Hsp90-dependent azole resistance is calcineurin, a protein phosphatase that regulates crucial responses to environmental stress, including the membrane stress exerted by exposure to azoles [20,21].”
BackgroundMethodInfluentialSelf-citationThe evolution of drug resistance in clinical isolates of Candida albicans.
Ford, C. B., Funt, J. M., Abbey, D., Issi, L., Guiducci, C., Martinez, D. A., Delorey, T., Li, B. Y., White, T. C., Cuomo, C., et al. (2015) · eLife · doi:10.7554/elife.00662 · Cited by 348
“…et al., 2008), as well as targeted alterations including increased expression of drug efflux genes (Coste et al., 2006), mutations in ergosterol biosynthetic genes (Asai et al., 1999; Oliver et al., 2007), and buffering by the chaperone heat shock protein 90 (Hsp90) (Cowen and Lindquist, 2005).”
InfluentialCryptic Variation in Morphological Evolution: HSP90 as a Capacitor for Loss of Eyes in Cavefish
Rohner, N., Jarosz, D. F., Kowalko, J. E., Yoshizawa, M., Jeffery, W. R., Borowsky, R. L., Lindquist, S., & Tabin, C. J. (2013) · Science · doi:10.1126/science.1240276 · Cited by 353
Self-citationChaperonin overexpression promotes genetic variation and enzyme evolution
Tokuriki, N., & Tawfik, D. S. (2009) · Nature · doi:10.1038/nature08009 · Cited by 352
Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
Carolus, H., Pierson, S., Lagrou, K., & Van Dijck, P. (2020) · Journal of Fungi · doi:10.3390/jof6040321 · Cited by 349
“Another mechanism of stress tolerance and/or resistance upon AmB exposure is likely governed by the molecular chaperone heat shock protein 90 (Hsp90), a highly connected, central factor in cellular stress responses that possibly potentiates the acquisition of resistance by regulating a myriad of client proteins [71,72…”
BackgroundInfluentialHsp90 and Environmental Stress Transform the Adaptive Value of Natural Genetic Variation
Jarosz, D. F., & Lindquist, S. (2010) · Science · doi:10.1126/science.1195487 · Cited by 346
Self-citationSelmecki, A. M., Dulmage, K., Cowen, L. E., Anderson, J. B., & Berman, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000705 · Cited by 319
“Consistent with this, stress response signaling through Hsp90 and/or calcineurin is required for fluconazole tolerance [36–38].”
BackgroundSelf-citationJackson, S. E. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_356 · Cited by 338
LaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329
“cerevisiae resistance due to an activating mutation in the transcription factor Pdr1 that causes overexpression of multidrug transporters including Pdr5 (Figure 8B), as was the case with inhibition of Hsp90 [25].”
BackgroundMethodInfluentialSelf-citationFitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., & Lindquist, S. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001692 · Cited by 322
“that promote resistance by mitigating the stress to the cell wall and membrane that is induced by these drugs [25,30,31].”
BackgroundMethodInfluentialSelf-citationMechanisms of echinocandin antifungal drug resistance
Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313
Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
Steinbach, W. J., Reedy, J. L., Cramer, R. A., Perfect, J. R., & Heitman, J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1680 · Cited by 313
Santagata, S., Hu, R., Lin, N. U., Mendillo, M. L., Collins, L. C., Hankinson, S. E., Schnitt, S. J., Whitesell, L., Tamimi, R. M., Lindquist, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115031108 · Cited by 311
“In yeast, HSP90, an important regulatory target of HSF1, potentiates the emergence of drug resistance by enabling the generation of greater phenotypic diversity (22).”
BackgroundSelf-citationHsp90 Orchestrates Temperature-Dependent Candida albicans Morphogenesis via Ras1-PKA Signaling
Shapiro, R. S., Uppuluri, P., Zaas, A. K., Collins, C., Senn, H., Perfect, J. R., Heitman, J., & Cowen, L. E. (2009) · Current Biology · doi:10.1016/j.cub.2009.03.017 · Cited by 311
Self-citationThe evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
Cowen, L. E. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1835 · Cited by 311
Self-citationPachl, J., Svoboda, P., Jacobs, F., Vandewoude, K., van der Hoven, B., Spronk, P., Masterson, G., Malbrain, M., Aoun, M., Garbino, J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/503428 · Cited by 307
“Hsp90 inhibitors not only have direct antifungal activity, but they may also prevent fungi from developing resistance to fluconazole or caspofungin [14, 15].”
BackgroundMolecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304
“One central cellular hub mediating antifungal drug tolerance and resistance is the molecular chaperone, Hsp90, which stabilizes various signal transducers involved in enabling antifungal-induced stress in Candida, Aspergillus , and Cryptococcus 74,75 .”
InfluentialSelf-citationHsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291
“A key mediator of Hsp90-dependent drug resistance is the protein phosphatase calcineurin [37,38,49].”
BackgroundInfluentialSelf-citationGoldstone, J. V., Hamdoun, A., Cole, B. J., Howard-Ashby, M., Nebert, D. W., Scally, M., Dean, M., Epel, D., Hahn, M. E., & Stegeman, J. J. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.066 · Cited by 280
“More recently, HSP90 has been shown to stabilize client proteins that are targets for toxicants, suggesting that HSP90 mediates the acquisition of drug resistance by stabilization of other proteins (Cowen and Lindquist, 2005).”
BackgroundRosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285
“In all cases tested, similar results were observed with the newer-generation triazole voriconazole (36).”
BackgroundResultInfluentialSelf-citationNetwork Hubs Buffer Environmental Variation in Saccharomyces cerevisiae
Levy, S. F., & Siegal, M. L. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060264 · Cited by 286
“cerevisiae according to our definition is consistent with a previous study that found that Hsp90 activity, not impairment, allowed new mutations to have immediate phenotypic consequence [35].”
ResultNLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning
Chen, X., Ren, B., Chen, M., Wang, Q., Zhang, L., & Yan, G. (2016) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004975 · Cited by 279
Life is Physics: Evolution as a Collective Phenomenon Far From Equilibrium
Goldenfeld, N., & Woese, C. (2011) · Annual Review of Condensed Matter Physics · doi:10.1146/annurev-conmatphys-062910-140509 · Cited by 276
“The physics of living systems would have at its core a generalized description of evolutionary processes, reflecting allowable dynamical symmetries, not merely static configurational ones.”
BackgroundCurrent Perspectives on Echinocandin Class Drugs
Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.19 · Cited by 274
Antifungal Drugs: The Current Armamentarium and Development of New Agents
Robbins, N., Wright, G. D., & Cowen, L. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0002-2016 · Cited by 271
“Com-promise of Hsp90 function also transforms azoles from fungistatic to fungicidal (82).”
BackgroundInfluentialSelf-citationEvolution of heat‐shock protein expression underlying adaptive responses to environmental stress
Chen, B., Feder, M. E., & Kang, L. (2018) · Molecular Ecology · doi:10.1111/mec.14769 · Cited by 267
Kassahn, K. S., Crozier, R. H., Pörtner, H. O., & Caley, M. J. (2009) · Biological Reviews · doi:10.1111/j.1469-185x.2008.00073.x · Cited by 263
“In laboratory selection experiments using yeast and Drosophila melanogaster, these new phenotypes rapidly become persistent beyond the application of the stress that revealed them, allowing for longerterm phenotypic change (Cowen & Lindquist, 2005; Rutherford & Lindquist, 1998).”
Hong, D. S., Banerji, U., Tavana, B., George, G. C., Aaron, J., & Kurzrock, R. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.10.001 · Cited by 259
Role of Heat-Shock Proteins in Cellular Function and in the Biology of Fungi
Tiwari, S., Thakur, R., & Shankar, J. (2015) · Biotechnology Research International · doi:10.1155/2015/132635 · Cited by 255
“albicans [86, 128, 129].”
On the origins of novelty in development and evolution
Moczek, A. P. (2008) · BioEssays · doi:10.1002/bies.20754 · Cited by 253
Hsp90 and co‐chaperones twist the functions of diverse client proteins
Zuehlke, A., & Johnson, J. L. (2010) · Biopolymers · doi:10.1002/bip.21292 · Cited by 251
Zhang, L., Yan, K., Zhang, Y., Huang, R., Bian, J., Zheng, C., Sun, H., Chen, Z., Sun, N., An, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609370104 · Cited by 248
Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris
Chatterjee, S., Alampalli, S. V., Nageshan, R. K., Chettiar, S. T., Joshi, S., & Tatu, U. S. (2015) · BMC Genomics · doi:10.1186/s12864-015-1863-z · Cited by 247
“To determine the in vitro susceptibility to antifungal drugs, broth microdilution protocol [52] was used.”
Combinatorial strategies for combating invasive fungal infections
Spitzer, M., Robbins, N., & Wright, G. D. (2017) · Virulence · doi:10.1080/21505594.2016.1196300 · Cited by 218
Non-genetic cell-to-cell variability and the consequences for pharmacology
Niepel, M., Spencer, S. L., & Sorger, P. K. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.09.015 · Cited by 215
“However, the proteome also influences epigenetic regulation of gene expression [14,15] and it has been suggested that the expression levels of certain proteins influence the probability that mutations will be fixed [16].”
Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo
Lee, K. K., MacCallum, D. M., Jacobsen, M. D., Walker, L. A., Odds, F. C., Gow, N. A. R., & Munro, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00683-11 · Cited by 209
Candida albicans drug resistance—Another way to cope with stress
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Tanabe, K., Niimi, M., & Monk, B. C. (2007) · Microbiology · doi:10.1099/mic.0.2007/010405-0 · Cited by 208
“In vitro studies have also demonstrated a role for Hsp90, a molecular chaperone for calcineurin, in promoting the rapid acquisition of fluconazole resistance by C. albicans (Cowen & Lindquist, 2005; Cowen et al., 2006).”
BackgroundPost-translational modifications of Hsp90 and translating the chaperone code
Backe, S. J., Sager, R. A., Woodford, M. R., Makedon, A. M., & Mollapour, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011833 · Cited by 205
“In fungi, particularly in pathogenic species, fungal Hsp90 mediates resistance to anti-fungals, such as azoles, by enabling resistance mutations and stabilizing resistance-mediating protein products (203, 204).”
BackgroundGlobal Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 205
Self-citationBiological Robustness: Paradigms, Mechanisms, and Systems Principles
Whitacre, J. M. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00067 · Cited by 191
“Evolutionary biologists are interested in mutational robustness because it deconstrains evolution at the molecular level (Cowen and Lindquist, 2005; Bloom et al., 2006; McBride et al., 2008) and at other levels of biological organization (Babajide et al., 1997; Aldana et al., 2007; Ciliberti et…”
BackgroundHsp90 Mediates Membrane Deformation and Exosome Release
Lauwers, E., Wang, Y.-C., Gallardo, R., Van der Kant, R., Michiels, E., Swerts, J., Baatsen, P., Zaiter, S. S., McAlpine, S. R., Gounko, N. V., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.016 · Cited by 184
Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus
Martinez-Rossi, N. M., Bitencourt, T. A., Peres, N. T. A., Lang, E. A. S., Gomes, E. V., Quaresemin, N. R., Martins, M. P., Lopes, L., & Rossi, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01108 · Cited by 183
Pribis, J. P., García-Villada, L., Zhai, Y., Lewin-Epstein, O., Wang, A. Z., Liu, J., Xia, J., Mei, Q., Fitzgerald, D. M., Bos, J., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.037 · Cited by 183
Sionov, E., Chang, Y. C., Garraffo, H. M., & Kwon-Chung, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-09 · Cited by 179
Protein Homeostasis and the Phenotypic Manifestation of Genetic Diversity: Principles and Mechanisms
Jarosz, D. F., Taipale, M., & Lindquist, S. (2010) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090412 · Cited by 179
Self-citationHSP90 affects the expression of genetic variation and developmental stability in quantitative traits
Sangster, T. A., Salathia, N., Undurraga, S., Milo, R., Schellenberg, K., Lindquist, S., & Queitsch, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712200105 · Cited by 174
“cerevisiae (12) and cancer cell lines (13).”
BackgroundResultSelf-citationUpdate on Antifungal Drug Resistance
Perlin, D. S., Shor, E., & Zhao, Y. (2015) · Current Clinical Microbiology Reports · doi:10.1007/s40588-015-0015-1 · Cited by 174
The fungal cell wall as a target for the development of new antifungal therapies
Cortés, J. C. G., Curto, M.-Á., Carvalho, V. S. D., Pérez, P., & Ribas, J. C. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.008 · Cited by 170
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans
Cui, J., Ren, B., Tong, Y., Dai, H., & Zhang, L. (2015) · Virulence · doi:10.1080/21505594.2015.1039885 · Cited by 171
“For example, radicicol and geldenamycin show potent synergistic antifungal activities with azoles by inhibiting the functions of Hsp90, a molecular chaperone to calcineurin.(69) The inhibitors of PKC1 (regulates cell wall integrity) render C.”
BackgroundVergnes, B., Gourbal, B., Girard, I., Sundar, S., Drummelsmith, J., & Ouellette, M. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600319-mcp200 · Cited by 170
“Recently HSP90 was shown to help fungi resist cytotoxic drugs before specific resistance mechanisms emerge (69).”
BackgroundThe origins of cancer robustness and evolvability
Tian, T., Olson, S., Whitacre, J. M., & Harding, A. (2011) · Integr. Biol. · doi:10.1039/c0ib00046a · Cited by 169
Seidl, V., Song, L., Lindquist, E., Gruber, S., Koptchinskiy, A., Zeilinger, S., Schmoll, M., Martínez, P., Sun, J., Grigoriev, I., et al. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-567 · Cited by 168
“The function of these proteins in other organisms is intriguing: HSP90 is a molecular chaperone for many signal transducers and has been postulated to be involved in releasing previously silent genetic variation in response to environmental changes [21], such as drug resistance, and this resistance can be abrogated by…”
BackgroundSangster, T. A., Bahrami, A., Wilczek, A., Watanabe, E., Schellenberg, K., McLellan, C., Kelley, A., Kong, S. W., Queitsch, C., & Lindquist, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000648 · Cited by 160
“HSP90 can suppress the phenotypic consequences of existing genetic polymorphisms [5,6], affect epigenetically inherited phenotypes [7], and facilitate the spread of novel mutations [8].”
BackgroundSelf-citationGenetic Architecture of Hsp90-Dependent Drug Resistance
Cowen, L. E., Carpenter, A. E., Matangkasombut, O., Fink, G. R., & Lindquist, S. (2006) · Eukaryotic Cell · doi:10.1128/ec.00274-06 · Cited by 159
“In fungi separated by 800 million years of evolution, we found that Hsp90 potentiates the rapid evolution of drug resistance (7).”
BackgroundInfluentialSelf-citationCalcineurin-Crz1 Signaling in Lower Eukaryotes
Thewes, S. (2014) · Eukaryotic Cell · doi:10.1128/ec.00038-14 · Cited by 166
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145
“the activation of efflux pumps (Figure 1) [29,31].”
BackgroundChaperoning a cellular upheaval in malaria: Heat shock proteins in Plasmodium falciparum
Acharya, P., Kumar, R., & Tatu, U. S. (2007) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2007.01.009 · Cited by 150
Emergence of a Candida krusei Isolate with Reduced Susceptibility to Caspofungin during Therapy
Hakki, M., Staab, J. F., & Marr, K. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00148-06 · Cited by 148
“Determining whether mutations exist in another region of FKS1 or in other genes associated with antifungal resistance (3) will require further study.”
BackgroundInfluentialMolecular Chaperones in Pathogen Virulence: Emerging New Targets for Therapy
Neckers, L., & Tatu, U. S. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.10.011 · Cited by 146
Fitness Trade-Offs and Environmentally Induced Mutation Buffering in Isogenic C. elegans
Casanueva, M. O., Burga, A., & Lehner, B. (2012) · Science · doi:10.1126/science.1213491 · Cited by 146
Shapiro, R. S., & Cowen, L. E. (2012) · mBio · doi:10.1128/mbio.00238-12 · Cited by 152
Self-citationRoles of Heat Shock Protein gp96 in the ER Quality Control: Redundant or Unique Function?
Yang, Y., & Li, Z. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13214-6 · Cited by 150
“, 2002; Rutherford and Lindquist, 1998), potentiating the evolution of new traits (Cowen and Lindquist, 2005) and involvement in tumor cell survival and invasion (Eustace et al.”
BackgroundTriazole Resistance in Aspergillus spp.: A Worldwide Problem?
Rivero-Menendez, O., Alastruey-Izquierdo, A., Mellado, E., & Cuenca-Estrella, M. (2016) · Journal of Fungi · doi:10.3390/jof2030021 · Cited by 142
Kim, S. H., Iyer, K. R., Pardeshi, L., Muñoz, J. F., Robbins, N., Cuomo, C. A., Wong, K. H., & Cowen, L. E. (2019) · mBio · doi:10.1128/mbio.02529-18 · Cited by 136
“regulators of cellular responses to drug-induced stress (8).”
BackgroundInfluentialSelf-citationUpdate on antifungal drug resistance mechanisms of Aspergillus fumigatus
Chamilos, G., & Kontoyiannis, D. P. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2006.01.001 · Cited by 162
“(2004), Cowen and Lindquist (2005)”
Fungal persister cells: The basis for recalcitrant infections?
Wuyts, J., Van Dijck, P., & Holtappels, M. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007301 · Cited by 136
Heat Shock Protein 90 Is Required for Conidiation and Cell Wall Integrity in Aspergillus fumigatus
Lamoth, F., Juvvadi, P. R., Fortwendel, J. R., & Steinbach, W. J. (2012) · Eukaryotic Cell · doi:10.1128/ec.00032-12 · Cited by 136
“As previously suggested (5, 8, 9), there are significant differences in the chaperoning network of Hsp90 and/or the Hsp90calcineurin interaction between yeasts and molds, possibly resulting in different mechanisms of resistance to various classes of antifungal agents.”
InfluentialAntifungal Pharmacokinetics and Pharmacodynamics
Lepak, A. J., & Andes, D. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019653 · Cited by 134
“…phenomenon include protein kinase C (Wiederhold et al. 2005; Shields et al. 2011), the calcineurin pathway (Wiederhold et al. 2005; Shields et al. 2011), the high-osmolarity glycerol response pathway (Popolo et al. 2001), and heat shock protein 90 (Cowen and Lindquist 2005; Kaneko et al. 2009).”
BackgroundLeach, M. D., Budge, S., Walker, L. A., Munro, C. A., Cowen, L. E., & Brown, A. J. P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003069 · Cited by 146
“Hsp90 modulates the phenotypic effects of genetic variation in an environmentally responsive manner [95,96,97,98], influencing approximately 20% of observed natural genetic variation and serving to maintain phenotypic robustness and promote diversification [96].”
BackgroundSelf-citationHSP90 Shapes the Consequences of Human Genetic Variation
Karras, G. I., Yi, S. S., Sahni, N., Fischer, M., Xie, J., Vidal, M., D’Andrea, A. D., Whitesell, L. J., & Lindquist, S. L. (2017) · Cell · doi:10.1016/j.cell.2017.01.023 · Cited by 131
“Previous work by us and others in various models has shown that the protein-folding buffer activity of HSP90 permits it to serve as both a potentiator and a capacitor of genetic variation (Cowen and Lindquist, 2005; Jarosz and Lindquist, 2010; Queitsch et al., 2002; Rohner et al., 2013; Rutherford and Lindquist, 1998;…”
InfluentialSelf-citation
Metadata
- Authors
- Cowen, L. E., & Lindquist, S.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Lindquist, Susan
- ORCID
- Cowen, Leah E.
- Venue
- Science
- Published
- 2005-09-30
- Volume
- 309
- Issue
- 5744
- Pages
- 2185-2189
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1988825409
- Cited by
- 698
- References
- 36
- Citations by year
- 2026: 21 · 2025: 32 · 2024: 46 · 2023: 30 · 2022: 30 · 2021: 38 · 2020: 34 · 2019: 42 · 2018: 36 · 2017: 25 · 2016: 34 · 2015: 36 · 2014: 39 · 2013: 40 · 2012: 47
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (P30ES002109, P30ES-02109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- HSP90, molecular chaperones, drug resistance, fungi, Hsp90 inhibitors, fever, febrile temperature, signal transducers, treatment options
- MeSH terms
- Caspofungin, Antifungal Agents, Aspergillosis, Aspergillus, Candida albicans, Candidiasis, Ergosterol, Biological Evolution, Humans, Mutation, Peptides, Cyclic, Phenotype, Saccharomyces cerevisiae, Selection, Genetic, Fluconazole, AIDS-Related Opportunistic Infections, HSP90 Heat-Shock Proteins, Calcineurin, Cyclophilin A, Drug Resistance, Fungal, Saccharomyces cerevisiae Proteins, Echinocandins, Lipopeptides, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.